IJMAX
Price
$13.48
Change
-$0.05 (-0.37%)
Updated
Oct 7 closing price
Net Assets
190.13M
VMVAX
Price
$90.37
Change
-$0.35 (-0.39%)
Updated
Oct 7 closing price
Net Assets
32.47B
Interact to see
Advertisement

IJMAX vs VMVAX

Header iconIJMAX vs VMVAX Comparison
Open Charts IJMAX vs VMVAXBanner chart's image
VY® JPMorgan Mid Cap Value A
Price$13.48
Change-$0.05 (-0.37%)
VolumeN/A
Net Assets190.13M
Vanguard Mid-Cap Value Index Admiral
Price$90.37
Change-$0.35 (-0.39%)
VolumeN/A
Net Assets32.47B
IJMAX vs VMVAX Comparison Chart in %
View a ticker or compare two or three
VS
IJMAX vs. VMVAX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IJMAX is a Buy and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 32.5B vs. IJMAX (190M). VMVAX pays higher dividends than IJMAX: VMVAX (2.17) vs IJMAX (0.64). IJMAX was incepted earlier than VMVAX: IJMAX (23 years) vs VMVAX (14 years). IJMAX (1.50) is less costly to investors than VMVAX (0.07). IJMAX is a more actively managed with annual turnover of: 25.00 vs. VMVAX (19.00). IJMAX has a lower initial minimum investment than VMVAX: IJMAX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 5.99 vs. IJMAX (-11.05). VMVAX return over 5 years is better than : 65.19 vs. IJMAX (0.76).
IJMAXVMVAXIJMAX / VMVAX
Total Expense Ratio1.350.071,929%
Annual Report Gross Expense Ratio1.500.072,143%
Fund Existence23 years14 years-
Gain YTD-11.5528.382-138%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets190M32.5B1%
Annual Yield % from dividends0.642.1729%
Returns for 1 year-11.055.99-185%
Returns for 3 years2.3142.635%
Returns for 5 years0.7665.191%
Returns for 10 years-23.83103.16-23%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEMMX48.42N/A
N/A
Fidelity Advisor Emerging Markets C
VVSCX12.90N/A
N/A
VALIC Company I Small Cap Value
JGECX13.19N/A
N/A
JHancock Global Equity C
LAVVX17.49N/A
N/A
Lord Abbett Fundamental Equity R6
TMCGX15.69-0.13
-0.82%
Thrivent Mid Cap Growth S